Immune suppression is a know risk
factor for developing NHL. It's also associated with disease
progression and a common side effect of standard treatments.
{beta}2-microglobulin
-[associated with NHL progression] as a negative regulator
of the immune system: high concentrations of the protein inhibit
in vitro generation of functional dendritic cells. Blood. 2003 Jan
16 PMID: 12531797 - PubMed
Th1/Th2 cytokine expression and its relationship with tumor
growth in B cell non-Hodgkin's lymphoma (NHL). Leuk Lymphoma. 2002
Jun;43(6):1313-21.
PMID: 12153001 - PubMed
The Prevalence of Blastocystis Hominis in Immunosuppressed
Patients
- ams.cu.edu.tr
Treatment-related
Pure red cell aplasia due to parvovirus following treatment
with CHOP and rituximab for B-cell lymphoma. Br J Haematol. 2002
Oct;119(1):125-7. PMID: 12358915 - PubMed
Frequency and type of serious infections in
fludarabine-refractory B-cell chronic lymphocytic leukemia and
small lymphocytic lymphoma: implications for clinical trials in
this patient population. Cancer. 2002 Apr 1;94(7):2033-9. PMID:
11932906 - PubMed
Epstein-Barr virus-positive B-cell lymphoproliferative
disorders arising in immunodeficient patients previously treated
with fludarabine for low-grade B-cell neoplasms. Am J Surg Pathol.
2002 May;26(5):630-6. PMID: 11979093 - PubMed
Incidence related
B-cell lymphomas involving the skin associated with hepatitis
C virus infection. Int J Dermatol. 2002 Sep;41(9):577-82. PMID:
12358827 - PubMed
